Subjects: DOENÇAS CEREBRAIS, BIOMARCADORES, RESSONÂNCIA MAGNÉTICA, VASOS SANGUÍNEOS, COGNIÇÃO
ABNT
ZOTIN, Maria Clara Zanon. Peak width of skeletonized mean diffusivity (PSMD) as neuroimaging biomarker for vascular cognitive impairment in the context of cerebral amyloid angiopathy. 2022. Tese (Doutorado) – Universidade de São Paulo, Ribeirão Preto, 2022. Disponível em: https://www.teses.usp.br/teses/disponiveis/17/17140/tde-01122022-122130/. Acesso em: 17 ago. 2024.APA
Zotin, M. C. Z. (2022). Peak width of skeletonized mean diffusivity (PSMD) as neuroimaging biomarker for vascular cognitive impairment in the context of cerebral amyloid angiopathy (Tese (Doutorado). Universidade de São Paulo, Ribeirão Preto. Recuperado de https://www.teses.usp.br/teses/disponiveis/17/17140/tde-01122022-122130/NLM
Zotin MCZ. Peak width of skeletonized mean diffusivity (PSMD) as neuroimaging biomarker for vascular cognitive impairment in the context of cerebral amyloid angiopathy [Internet]. 2022 ;[citado 2024 ago. 17 ] Available from: https://www.teses.usp.br/teses/disponiveis/17/17140/tde-01122022-122130/Vancouver
Zotin MCZ. Peak width of skeletonized mean diffusivity (PSMD) as neuroimaging biomarker for vascular cognitive impairment in the context of cerebral amyloid angiopathy [Internet]. 2022 ;[citado 2024 ago. 17 ] Available from: https://www.teses.usp.br/teses/disponiveis/17/17140/tde-01122022-122130/